![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 36, 32546-32551, September 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 14, 2002, and in revised form, June 11, 2002
There is increasing evidence that intracellular
reactive oxygen species (ROS) play a role in cell signaling and that
the NADPH oxidase is a major source of ROS in endothelial cells. At low concentrations, agonist stimulation of membrane receptors generates intracellular ROS and repetitive oscillations of intracellular Ca2+ concentration
([Ca2+]i) in human endothelial cells. The
present study was performed to examine whether ROS are important in the
generation or maintenance of [Ca2+]i oscillations
in human aortic endothelial cells (HAEC) stimulated by histamine.
Histamine (1 µM) increased the fluorescence of
2',7'-dihydrodichlorofluorescin diacetate in HAEC, an indicator of ROS production. This was partially inhibited by the NADPH oxidase inhibitor diphenyleneiodonium (DPI, 10 µM), by the
farnesyltransferase inhibitor H-Ampamb-Phe-Met-OH (2 µM),
and in HAEC transiently expressing Rac1N17, a dominant
negative allele of the protein Rac1, which is essential for NADPH
oxidase activity. In indo 1-loaded HAEC, 1 µM histamine triggered [Ca2+]i oscillations that were blocked
by DPI or H-Ampamb-Phe-Met-OH. Histamine-stimulated
[Ca2+]i oscillations were not observed in HAEC
lacking functional Rac1 protein but were observed when transfected
cells were simultaneously exposed to a low concentration of hydrogen
peroxide (10 µM), which by itself did not alter either
[Ca2+]i or levels of inositol 1,4,5-trisphosphate
(Ins-1,4,5-P3). Thus, histamine generates ROS in HAEC at
least partially via NADPH oxidase activation. NADPH oxidase-derived ROS
are critical to the generation of [Ca2+]i
oscillations in HAEC during histamine stimulation, perhaps by
increasing the sensitivity of the endoplasmic reticulum to
Ins-1,4,5-P3.
There is increasing evidence that intracellular reactive oxygen
species (ROS)1 play an
important role in cell signaling (1-4). Both vascular smooth muscle
cells and endothelial cells are capable of generating ROS (5). A number
of enzyme systems likely contribute to ROS generation in endothelial
cells, including arachidonic acid-metabolizing systems (6), the
mitochondrial electron transport chain (7), xanthine oxidase (8),
nitric-oxide synthase (9), the cytochrome P450 enzyme system
(10), and endothelial NADPH oxidase (11). The endothelial NADPH oxidase
shares some structural features of the multicomponent NADPH oxidase of
phagocytes, most of which have been identified in endothelial cells at
the RNA or protein level (12-14). Among these include the small
GTP-binding protein Rac1, which is necessary for enzyme function.
Whereas the oxidase of phagocytes generates large quantities of ROS
that are necessary to eliminate engulfed microorganisms, the NADPH
oxidase of non-phagocytic cells generates low levels of ROS that appear
to have a cell signaling function.
ROS generation by endothelial cells has been observed after stimulation
by acetylcholine (15), interleukin-4 (16), interleukin-1 (17),
interferon- At low concentrations, agonists like histamine (30), bradykinin (31),
and thrombin (32) stimulate repetitive oscillations of intracellular
Ca2+ concentration ([Ca2+]i) in
endothelial cells. The initiation of each Ca2+ spike
appears to be due chiefly to the generation of Ins-1,4,5-P3 (33), and the maintenance of oscillations may be related to repetitive
cycles of fast activation and slow inactivation of the
Ins-1,4,5-P3 receptor by Ca2+ (34, 35). Thus,
the observation, that NADPH oxidase-generated ROS increases the
sensitivity of intracellular Ca2+ stores to
Ins-1,4,5-P3, suggests a potential link between oxidase stimulation and Ca2+ signaling. The following study was
therefore performed to determine whether NADPH oxidase-generated ROS
affect [Ca2+]i oscillations during histamine
stimulation in human endothelial cells.
Endothelial Cell Culture--
Human aortic endothelial cells
(HAEC) were obtained as proliferating quaternary cultures (Clonetics,
San Diego, CA) and were grown to confluence to passages 5-9
in endothelial cell growth medium supplemented with 2% fetal bovine
serum, 10 µg/liter human recombinant epidermal growth factor, 1 mg/liter hydrocortisone, 50 µg/ml gentamicin, 50 ng/ml
amphotericin-B, 12 µg/ml bovine brain extract (Clonetics) in a
37 °C humidified atmosphere of 95% air-5% CO2. To
measure [Ca2+]i, HAECs were grown on
25-mm-diameter circular glass coverslips (VWR Scientific, Media, PA)
precoated with 2% gelatin solution (Sigma Chemical Co.) for at least
2 h at 37 °C. The glass coverslips were washed three times with
phosphate-buffered saline (Quality Biological, Inc., Gaithersburg, MD)
before cell seeding. After exposure to a solution of 0.025% trypsin
and 0.01% EDTA (Sigma), HAECs were plated at an approximate
concentration of 1 × 105/ml on the glass coverslips.
Cells were used for experiments after reaching ~70% confluence after
incubation for 1-2 days at 37 °C in a humidified atmosphere of 95%
air-5% CO2.
Measurement of Intracellular ROS Generation in
HAEC--
Detection of intracellular ROS was performed by a previously
established method using the ROS-sensitive fluorescent probe 2',7'-dihydrodichlorofluorescin diacetate (DCF-DA) and confocal microscopy (1, 36). For measurement of intracellular ROS, HAECs were
plated in a chamber slide system (Fisher Sciences, Newark, DE) at a
density of 1 × 105 cells/ml and then cultured for 3 days. The cells were washed with HEPES-buffered saline (HBS) and were
loaded with 5 µg/ml of DCF-DA (Molecular Probes, Eugene, OR) for 5 min at 37 °C. The fluorescent dichlorofluorescin was quantified by
using a laser-scanning confocal microscope (Leica TCS-4D, Heidelberg,
Germany) with the excitation and emission wavelengths of 488 and 520 nm, respectively.
Measurement of [Ca2+]i--
HAEC
[Ca2+]i was measured as previously described (37)
using the fluorescent Ca2+ probe indo 1. Briefly, HAEC in
tissue culture dishes were exposed to a solution of 0.025% trypsin and
0.01% EDTA (Sigma Chemical Co., St. Louis, MO) and were then plated at
a concentration of ~1 × 105/ml on 25-mm-diameter
circular glass coverslips (VWR Scientific, Media, PA) precoated with
2% gelatin solution (Sigma) for at least 2 h at 37 °C. Cells
were used for experiments after reaching ~70% confluence after
incubation for 1-2 days at 37 °C in a humidified atmosphere of 95%
air-5% CO2. To measure [Ca2+]i, HAEC
monolayers on glass coverslips were incubated with culture medium
containing 10 µM of the ester derivative (acetoxymethyl ester form) of indo 1 (Molecular Probes, Eugene, OR) in a room temperature 95% air-5% CO2 atmosphere for 30 min. The
coverslips were then gently washed three times with indicator-free HBS
of the following composition (in millimolar): NaCl 137, KCl 4.9, CaCl2 1.5, MgSO4 1.2, NaH2PO4 1.2, D-glucose 15, HEPES 20 (pH adjusted to 7.40 at room temperature with NaOH). The cells were maintained in HBS for at least 30 min before the beginning of the
experiment to allow for de-esterification of the indicator. The
fluorescence of indo 1 was recorded from single HAEC on coverslips in a
perfusion chamber mounted on the stage of a modified Nikon Diaphot
inverted epifluorescence microscope. The fluorescence of indo 1 was
excited at 350 ± 50 nm using a xenon short arc lamp (UXL-75 XE,
Ushio Inc., Japan), and bandpass interference filters (Omega Optical,
Brattleboro, VT) with selected wavelength bands of emitted fluorescence
at 405 ± 10 nm and 485 ± 10 nm, corresponding to the
Ca2+-bound and Ca2+-free forms of the
indicator, respectively. Emitted indo 1 fluorescence was collected and
measured using a spectrofluorometer (PTI, Deltascan). The photometer
had a series of fixed-pinhole diaphragms to regulate the recording
field area. Autofluorescence from unloaded HAEC was generally <5% of
indo 1-loaded HAEC and was subtracted automatically from indo 1 fluorescence recordings.
To determine [Ca2+]i from indo 1 fluorescence
ratios, the intracellular minimum and maximum ratios
(Rmin and Rmax, respectively) were determined as previously described (37). To
determine Rmin, indo 1-loaded HAECs on the glass
coverslips were perfused with a solution containing (in millimolar):
NaCl 137, KCl 5.0, MgSO4 1.2, NaH2PO4 1.2, D-glucose 16, HEPES
10, and EGTA 2, pH 7.40. HAECs were then exposed to a solution of similar composition except with 10 mM EGTA and 0.05%
Triton X-100. An intracellular Rmax value was
determined by first perfusing HAEC with a solution containing 132 mM KCl, 10 mM K-HEPES, 1 mM MgSO4, 2 µM rotenone (Sigma), 2 µM carbonyl cyanide
p-trifluoromethoxyphenylhydrozone (Sigma), and 10 ng/ml
valinomycin (Calbiochem, La Jolla, CA). HAECs were then exposed to
a similar solution containing 2 µM ionomycin (Sigma),
69.2 mM CaCl2, and 100 mM
HEPES (free [Ca2+] of 5900 nM). The
values of intracellular Rmin and
Rmax were used to calculate
[Ca2+]i according to the following formula (38):
[Ca2+]i = Kd
(R HAEC Transiently Expressing the Dominant Negative Allele of
Rac1--
An adenovirus encoding the Myc epitope-tagged, dominant
negative Rac1 cDNA containing a substitution at position 17 (Rac1N17) was used as described previously (4).
Expression of the Rac1N17 mutant was confirmed by protein
immunoblotting with an antibody to the Myc epitope (9E10, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA).
Ins-1,4,5-P3 Measurement--
To measure
Ins-1,4,5-P3 levels, HAECs were stimulated with histamine
or other agonists, the reaction was stopped by adding 1 M
ice-cold trichloroacetic acid, and the cells were maintained for 15 min
on ice. The cells were then scraped and centrifuged at 1000 × g for 10 min at 4 °C. The supernatant was removed and incubated for 15 min at room temperature. Levels of
1,4,5-InsP3 in each supernatant were determined using a
3H-label Radioreceptor Assay kit (PerkinElmer Life
Sciences, Inc., Boston, MA) according to the manufacturer's
instructions. Duplicate measurements were performed for each separate
experiment. Cellular Ins-1,4,5-P3 levels were
normalized as -fold increase of paired-control experiments in
unstimulated HAEC.
Statistical Analysis--
Data are reported as mean ± S.E.
Statistical comparisons were made using Student's t test
for the paired and the unpaired groups. An analysis of variance was
used when multiple comparisons were performed. A difference was
considered significant at p < 0.05.
Histamine Stimulates Intracellular ROS Generation in HAEC--
The
effect of 1 µM histamine on intracellular ROS generation
was examined in DCF-loaded HAEC by confocal microscopy. This concentration of histamine triggers [Ca2+]i
oscillations in human endothelial cells (30, 39). As shown in Fig.
1, 1 µM histamine
stimulated intracellular ROS generation in a time-dependent
manner (Fig. 1A). Histamine increased DCF fluorescence
intensity in HAEC by 21.4 ± 8.9%, 54.3 ± 13.8%, and
213.8 ± 33.3% at 1, 5, and 10 min, respectively
(p < 0.01 versus control at 5 and 10 min,
n = 9 for each). As shown in Fig. 1B, the
increase in DCF fluorescence stimulated by histamine was markedly
attenuated by the NADPH oxidase inhibitor DPI and by the
farnesyltransferase (FTase) inhibitor H-Ampamb-Phe-Met-OH (LC
Laboratories, Woburn, MA). FTase inhibitors inhibit the
post-translational modification (the covalent addition of a 15-carbon
farnesyl group) of Ras family GTP-binding proteins, including Rac1,
which is essential for NADPH oxidase activity. Farnesylation is
necessary for membrane association and biologic activity of these
proteins (40, 41). In the presence of 10 µM DPI or 2 µM FTase inhibitor, concentrations previously shown to
inhibit ROS generation in HAEC (42) and fibroblasts (4), respectively,
histamine-stimulated DCF fluorescence was inhibited by ~60-70%
(60.0 ± 12.0% for DPI and 85.6 ± 18.8% for FTase
inhibitor versus 213.8 ± 33.3% at 10 min,
p < 0.05 for each). Histamine-stimulated DCF
fluorescence was also markedly attenuated in HAEC transiently
expressing Rac1N17, a dominant negative allele of Rac1 (4).
As shown in Fig. 1C, DCF fluorescence was ~50% lower in
cells lacking functional Rac1 protein compared with vector controls
(119.1 ± 13.5 versus 228.7 ± 70.5% after 10 min, p < 0.05, n = 4).
Regulation of Histamine-stimulated [Ca2+]i
Oscillations by Intracellular ROS--
As previously demonstrated by
our laboratory (39) and others (30), 1 µM histamine
triggered [Ca2+]i oscillations in all control
HAEC studied (Fig. 2A). By
contrast, [Ca2+]i oscillations were not observed
in any HAEC expressing the dominant negative form of Rac1
(n = 16). In 14 of 16 cells, no change in
[Ca2+]i was noted, and, in the other 2 HAEC
expressing the dominant negative form of Rac1, only a single
[Ca2+]i spike was observed. Expression of the
Rac1N17 mutant did not appear to have a more general effect
on Ca2+ signaling, because even in those cells lacking any
[Ca2+]i response to 1 µM histamine,
the response to 100 µM histamine or to 1 µM
ionomycin (Fig. 2B) was preserved. To determine whether
expression of the dominant negative isoform of Rac1 inhibited [Ca2+]i oscillations by blocking ROS generation,
experiments were performed to determine whether
[Ca2+]i oscillations would be triggered by
histamine in cells lacking functional Rac1 protein in the presence of
exogenous hydrogen peroxide (H2O2).
H2O2 was employed for these studies rather than a superoxide-generating system, because our previous work showed that
the increased sensitivity of intracellular Ca2+ stores to
Ins-1,4,5-P3 stimulated by NADPH oxidase activity was also
blocked by catalase but was unaffected by superoxide dismutase (29). As
shown in Fig. 2C (top), 10 µM
H2O2 alone did not affect [Ca2+]i in HAEC, as previously shown in our
laboratory (43). Whereas 1 µM histamine did not stimulate
Ca2+ signaling in HAECs expressing the dominant negative
form of Rac1, [Ca2+]i oscillations were observed
after the simultaneous addition of 10 µM
H2O2 in 5 of 7 HAECs examined (Fig.
2C, bottom), and in another a single
[Ca2+]i spike was observed. To determine whether
the effect of H2O2 was related to an increase
in the sensitivity of intracellular Ca2+ stores to
Ins-1,4,5-P3 (29) or to an effect on
Ins-1,4,5-P3 levels, Ins-1,4,5-P3 levels were
measured in HAEC treated with 1 µM histamine or 10 µM H2O2 alone or with the two
together. As shown in Fig. 2D, 1 µM histamine
alone produced a rapid increase in Ins-1,4,5-P3
levels, with a 1.56 ± 0.25-fold increase evident 1 min after stimulation. H2O2 did not affect
Ins-1,4,5-P3 levels by itself and did not alter the effect
of histamine on Ins-1,4,5-P3 levels (1.63 ± 0.16-fold
increase at 1 min, p = NS compared with histamine
alone, n = 3 for each).
Additional experiments were performed to assess whether blocking the
generation of ROS by the NADPH oxidase affects histamine-stimulated [Ca2+]i oscillations in HAEC. In these
experiments (Fig. 3), [Ca2+]i oscillations were generated and then
cells were exposed to histamine-free buffer either alone (Fig.
3A), with DPI (Fig. 3B), or with the FTase
inhibitor (Fig. 3C) before a second exposure to histamine.
After [Ca2+]i oscillations were generated in the
presence of histamine, the washout of histamine resulted in the
cessation of oscillations. When the cell was stimulated again with
histamine after approximately a 10-min washout period,
[Ca2+]i oscillations recurred without any
significant difference in oscillation amplitude ( This study shows that histamine, like many other
agonists (15-28), stimulates the production of ROS in endothelial
cells. Histamine-stimulated ROS production results, at least in part, from activation of the NADPH oxidase and Rac1 signaling, because it is
inhibited by the NADPH oxidase inhibitor DPI, by an FTase inhibitor,
and in cells lacking functional Rac1 protein.
The generation of ROS by the NADPH oxidase was previously reported when
endothelial cells were stimulated by thrombin (28), vascular
endothelial growth factor (21), or tumor necrosis factor- The effect of NADPH oxidase activation on [Ca2+]i
oscillations may derive from the sensitization of the ER
Ins-1,4,5-P3 receptor by oxidase-derived ROS.
Ins-1,4,5-P3 is critical to the generation of
[Ca2+]i oscillations in non-excitable cells (33).
Like many other agonists, histamine binds to membrane receptors and
activates phospholipase C to hydrolyze phosphatidylinositol
4,5-bisphosphate and to generate diacylglycerol and
Ins-1,4,5-P3 (44). The generation of
Ins-1,4,5-P3 after agonist stimulation leads to the release of ER Ca2+. [Ca2+]i oscillations are
believed to depend on Ins-1,4,5-P3 receptors releasing
Ca2+ in "hotspots" in the ER (45) and the subsequent
diffusion of this Ca2+ to adjacent sites in the ER,
increasing the local sensitivity of the Ins-1,4,5-P3
receptor and inducing further Ca2+ release. Changes in the
sensitivity of the ER to Ins-1,4,5-P3 are likely to be
important in the generation of repetitive [Ca2+]i
spikes. Redox sensitivity of the Ins-1,4,5-P3 receptor has
previously been reported in hepatocytes (46-48), and we previously showed that NADPH oxidase activation increases the sensitivity of
intracellular Ca2+ stores to Ins-1,4,5-P3 in
HAEC. The finding, that 10 µM
H2O2 "restores"
[Ca2+]i oscillations in histamine-stimulated HAEC
expressing the dominant negative form of Rac1 but does not affect
Ins-1,4,5-P3 levels in histamine-stimulated HAEC, is
consistent with the notion that histamine-stimulated ROS increase
Ins-1,4,5-P3 receptor sensitivity and thereby affect the
generation of [Ca2+]i oscillations.
Histamine-stimulated ROS may also affect upstream signaling pathways in
HAEC. For example, we recently showed that activation of phospholipase
D (PLD), which exhibits redox sensitivity in endothelial cells (49),
regulates [Ca2+]i oscillation frequency in HAEC
during histamine stimulation (50). It is not likely that the effect of
histamine-stimulated ROS on the generation of
[Ca2+]i oscillations is related to PLD signaling,
however, because time-dependent activation of PLD by
histamine in HAEC is not rapid enough to affect generation of
oscillations. Stimulation of HAEC by histamine activates PLD by 5 min,
but no significant effect is observed 1 min after stimulation.
Moreover, inhibition of PLD decreases oscillation frequency, but does
not inhibit the generation of [Ca2+]i
oscillations during histamine stimulation (50). Alternatively,
histamine-stimulated ROS may modulate [Ca2+]i
oscillations by an effect on PLC- ROS may also be important in the generation of
[Ca2+]i oscillations, because of an effect on
other redox-sensitive Ca2+ release mechanisms that are
activated by histamine. For example, the ryanodine receptor (RyR) may
be important in histamine-stimulated Ca2+ signaling. It was
previously shown that blocking ryanodine-sensitive Ca2+
release inhibits [Ca2+]i oscillations in
endothelial cells stimulated by histamine (53). Redox regulation of the
RyR is well-established in cardiac and skeletal muscle, with sulfhydryl
oxidation, S-nitrosylation, or modification of sulfhydryl
groups of the RyR by other oxidants increasing Ca2+ release
channel activity (54). Hyper-reactive cysteine moieties may represent
biochemical components of a transmembrane redox sensor within the RyR
channel complex that conveys information about localized changes in
redox potential produced by different stimuli (55, 56).
The finding that ROS play a role in agonist-stimulated Ca2+
signaling is novel and important in cell biology, reinforcing the relatively new concept that ROS are not only important
pathophysiologically but also play major roles in cell signaling. It
was recently shown, for example, that epidermal growth factor increases
[Ca2+]i in fibroblasts without affecting inositol
phosphates but rather via the production of
H2O2 regulated by Rac and RhoA (57). This
finding is interesting in light of our previous work showing that
H2O2 increases the sensitivity of the ER
Ca2+ store to Ins-1,4,5-P3 (29) and that
H2O2 generates [Ca2+]i
oscillations in endothelial cells (43), even though H2O2 itself does not stimulate
Ins-1,4,5-P3 production, as shown in this work and by
others (58).
The present study shows that elevated levels of
Ins-1,4,5-P3 alone may not be sufficient to initiate
repetitive [Ca2+]i spiking behavior in HAEC
during histamine stimulation. Although histamine increases levels of
Ins-1,4,5-P3 (44), the generation of ROS during histamine
stimulation is necessary for oscillations to be triggered. More
specifically, it appears that NADPH oxidase-derived ROS are important
in histamine-triggered Ca2+ signaling, because oscillations
were not observed in the presence of DPI, an FTase inhibitor or in
dominant negative Rac1 transfected cells. The critical role of ROS in
the generation of [Ca2+]i oscillations is further
supported by the finding that 10 µM
H2O2 "restored"
[Ca2+]i oscillations in histamine-stimulated HAEC
expressing the dominant negative form of Rac1, even though this
concentration of H2O2 alone did not affect
Ca2+ signaling or Ins-1,4,5-P3 levels. Taken
together, these data suggest that histamine activates an NADPH oxidase
in HAEC, resulting in the production of ROS that increase the
sensitivity of the Ins-1,4,5-P3 receptor to
Ins-1,4,5-P3 and thereby play a role in the generation of
[Ca2+]i oscillations.
We thank Dr. Steve N. Georas and Dr. Jia Guo
for expert technical assistance and insightful comments.
*
This work was supported by a Beginning-Grant-in-Aid
0060165U from the American Heart Association Mid-Atlantic Affiliate (to Q. H.) and by National Institutes of Health Grant R01 HL63720 (to
R. C. Z.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of Medicine,
Division of Cardiology, Johns Hopkins Bayview Medical Center, 5501 Hopkins Bayview Circle 1A32, Baltimore, MD 21224-2780. Tel.: 410-550-6728; Fax: 410-550-1094; E-mail: ginghuaa@jhmi.edu.
Published, JBC Papers in Press, July 1, 2002, DOI 10.1074/jbc.M201550200
The abbreviations used are:
ROS, reactive oxygen
species;
Ins-1, 4,5-P3, inositol 1,4,5-triphosphate;
HAEC, human aortic endothelial cells;
[Ca2+]i, intracellular free calcium;
ER, endoplasmic reticulum;
DPI, diphenyleneiodonium;
DCF-DA, 2',7'-dihydrodichlorofluorescin diacetate;
HBS, HEPES-buffered saline;
PLD, phospholipase D;
PLC, phospholipase C;
RyR, ryanodine receptor.
Critical Role of NADPH Oxidase-derived Reactive Oxygen Species in
Generating Ca2+ Oscillations in Human Aortic Endothelial
Cells Stimulated by Histamine*
¶,
,
, and
Department of Medicine, Division of
Cardiology, Johns Hopkins Bayview Medical Center, Johns Hopkins
University School of Medicine, Baltimore, Maryland 21224 and the
§ Pathology Section, NHLBI, National Institutes of
Health, Bethesda, Maryland 20892
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(17), bradykinin (18, 19), platelet-activating factor
(20), vascular endothelial growth factor (21), tumor necrosis
factor (22-25), angiotensin II (26, 27), and thrombin (28). In several
circumstances, this ROS production has been shown to result from
activation of endothelial NADPH oxidase (24, 27, 28). We recently
showed that activation of endothelial NADPH oxidase increases the
sensitivity of endoplasmic reticulum (ER) Ca2+ stores to
inositol 1,4,5-trisphosphate (Ins-1,4,5-P3) (29). Activation of the NADPH oxidase in human aortic endothelial cells (HAEC) shifted the Ins-1,4,5-P3-Ca2+ release
dose-response curve to the left and decreased the threshold concentration of Ins-1,4,5-P3 required to release
intracellularly stored Ca2+. This effect was blocked by the
NADPH oxidase inhibitor diphenyleneiodonium (DPI) and was not observed
in cells lacking functional Rac1 protein.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Rmin)/(Rmax
R)(Sf2/Sb2),
where Kd is the dissociation constant of indo 1, and
Sf2 and Sb2 are
the fluorescence intensities at ~490 nm of the Ca2+-free
and Ca2+-saturated indicator, respectively.
Kd was determined to be 207 nM under the
present experimental conditions using an in vitro
calibration method.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 1.
Effect of histamine on ROS generation in
HAEC. A, representative changes in the fluorescence of
2',7'-dihydrodichlorofluorescin diacetate (DCF-DA) in HAEC treated with
100 µM H2O2 (top),
with 1 µM histamine (middle) or unstimulated
(bottom) examined by confocal microscopy (×100) and
photographed at 0, 5, and 10 min. B, averaged data showing
that the increase in DCF fluorescence stimulated by histamine
(solid circles) is inhibited by diphenyleneiodonium (DPI, 10 µM, open circles) or a farnesyltransferase
(FTase) inhibitor (H-Ampamb-Phe-Met-OH, 2 µM, solid triangles). The change in DCF
fluorescence is expressed as a percentage increase above baseline
fluorescence after subtraction of the small increase in DCF
fluorescence observed in control cells over time (data represent
mean ± S.E. of nine experiments for histamine alone and three and
five experiments for cells treated with DPI and the FTase inhibitor,
respectively; *, p < 0.05; **, p < 0.01 versus control). C, averaged data showing
that the increase in DCF fluorescence stimulated by histamine
(solid bars) is less in dominant negative Rac transfected
cells which lack functional Rac1 protein (open bars). The
change in DCF fluorescence is expressed as a percentage increase
above baseline fluorescence after subtraction of the small increase in
DCF fluorescence observed in control cells over time (data represent
mean ± S.E. of four experiments in each group; *,
p < 0.05 versus control).

View larger version (24K):
[in a new window]
Fig. 2.
Histamine does not trigger
[Ca2+]i oscillations in HAEC lacking functional
Rac 1 protein. A, representative tracing of seven
similar experiments from indo 1-loaded vector control HAEC exposed to
histamine (1 µM) in HEPES buffer with 1.5 mM
Ca2+. Histamine stimulated repetitive
[Ca2+]i oscillations over at least a 100-min
period of observation (slightly less than 30-min shown). B,
representative tracing from indo 1-loaded dominant negative
Rac-transfected HAEC exposed to 1 µM histamine. Histamine
did not trigger any [Ca2+]i spike in 14 of 16 Rac
dominant negative transfected HAEC examined; a single
[Ca2+]i spike was induced in the remaining two
HAEC expressing the dominant negative form of Rac1. Even when histamine
failed to affect [Ca2+]i, the response to the
Ca2+ ionophore ionomycin (1 µM) was
preserved. C, representative tracing from indo 1-loaded HAEC
showing that 10 µM H2O2 alone
does not affect [Ca2+]i (top).
Although 10 µM H2O2 by itself did
not trigger [Ca2+]i oscillations in HAEC
expressing the dominant negative form of Rac1 (bottom),
[Ca2+]i oscillations were observed when 10 µM H2O2 was added during
continued exposure to histamine in 5 of 7 HAEC expressing the dominant
negative form of Rac1; in another, a single
[Ca2+]i spike was observed. D,
averaged data showing that 1 µM histamine (solid
circles) increases levels of Ins-1,4,5-P3, whereas 10 µM H2O2 has no effect, either
alone (solid triangles), or in combination with histamine
(open circles). Data represent the mean ± S.E. of
three experiments in each group.
indo 1 ratio = 1.20 ± 0.21 versus 1.14 ± 0.24, p = NS) or frequency (0.28 ± 0.02 versus 0.23 ± 0.04 min
1,
p = NS) when compared with that observed before the
10-min washout (Fig. 3A). By contrast, repetitive
[Ca2+]i oscillations were not observed when
either 10 µM DPI (Fig. 3B) or 2 µM FTase inhibitor (Fig. 3C) was present
during and after histamine washout. Of note, DPI (up to 20 min) did not affect the content of cellular ATP, which is used for the biosynthesis of Ins-1,4,5-P3, as measured by bioluminescent method (data
not shown).

View larger version (14K):
[in a new window]
Fig. 3.
Histamine-stimulated
[Ca2+]i oscillations are blocked by NADPH oxidase
inhibition. A, representative tracing of five similar
experiments from indo 1-loaded HAEC stimulated sequentially by 1 µM histamine with a 10-min washout period between
exposures. Repetitive [Ca2+]i oscillations were
observed during histamine stimulation but not during washout.
B, representative tracing of four similar experiments from
indo 1-loaded HAEC stimulated by 1 µM histamine first in
control buffer and then a second time in the presence of 10 µM DPI. Only a single [Ca2+]i spike
and no oscillations were observed in the presence of DPI. C,
representative tracing of three similar experiments from indo 1-loaded
HAEC stimulated by 1 µM histamine first in control buffer
and then a second time in the presence of 2 µM FTase
inhibitor. Only a single [Ca2+]i spike was
observed in two of three HAEC; in a third, several irregularly
occurring [Ca2+]i spikes with decreasing
amplitude were observed over ~15 min, and then no further increases
in [Ca2+]i occurred during the observation
period.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(7,
22-25). In the case of tumor necrosis factor, NADPH oxidase-derived ROS were found to be important in activating nuclear factor-
B (NF-
B) in endothelial cells (24). NF-
B activation was previously shown to be redox-sensitive in HeLa cells (36). In HeLa cells, transient expression of a constitutively active Rac1 mutant increased NF-
B transcriptional activity, whereas basal and cytokine-stimulated NF-
B activity was inhibited in dominant negative Rac1 mutants. This
is interesting, because we previously showed that
[Ca2+]i oscillations regulate NF-
B activity
during histamine stimulation in HAEC (39), and now show that NADPH
oxidase-derived ROS are critical to the generation of
[Ca2+]i oscillations during histamine stimulation.
, because generation of
Ins-1,4,5-P3 by agonists like bradykinin appears to be
secondary to tyrosine phosphorylation of PLC-
1 (51) and
H2O2 is known to activate PLC-
(52). We do
not believe this mechanism is likely to play a role during histamine
stimulation, because 1 µM histamine stimulated only weak
tyrosine phosphorylation of PLC-
1 and histamine-stimulated tyrosine
phosphorylation of PLC-
2 was not inhibited by DPI, by an FTase
inhibitor, or in cells lacking functional Rac1 protein (data not shown).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Dr. Ferrans passed away shortly before submission of the manuscript.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Sundaresan, M., Yu, Z.-X.,
Ferrans, V. J.,
Irani, K.,
and Finkel, T.
(1995)
Science
270,
296-299 2.
Lander, H. M.,
Milbank, A. J.,
Tauras, J. M.,
Hajjar, D. P.,
Hempstead, B. L.,
Schwartz, G. D.,
Kraemer, R. T.,
Mirza, U. A.,
Chait, B. T.,
Campbell-Burk, S.,
and Quilliam, L. A.
(1996)
Nature
381,
380-381[CrossRef][Medline]
[Order article via Infotrieve]
3.
Lander, H. M.
(1997)
FASEB J.
11,
118-124[Abstract]
4.
Irani, K.,
Xia, Y.,
Zweier, J. L.,
Sollott, S. J.,
Der, C. J.,
Fearon, E. R.,
Sundaresan, M.,
Finkel, T.,
and Goldschmidt-Clermont, P. J.
(1997)
Science
275,
1649-1652 5.
Irani, K.
(2000)
Circ. Res.
87,
179-183 6.
Cosentino, F.,
Sill, J. C.,
and Katusic, Z. S.
(1994)
Hypertension
23,
229-235 7.
Corda, S.,
Laplace, C.,
Vicaut, E.,
and Duranteau, J.
(2001)
Am. J. Respir. Cell Mol. Biol.
24,
762-768 8.
Zweier, J. L.,
Kuppusamy, P.,
and Lutty, G. A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4046-4050 9.
Kerr, S.,
Brosnan, M. J.,
McIntyre, M.,
Reid, J. L.,
Dominiczak, A. F.,
and Hamilton, C. A.
(1999)
Hypertension
33,
1353-1358 10.
Fleming, I.,
Michaelis, U. R.,
Bredenkotter, D.,
Fisslthaler, B.,
Dehghani, F.,
Brandes, R. P.,
and Busse, R.
(2001)
Circ. Res.
88,
44-51 11.
Babior, B. M.
(2000)
IUBMB Life
50,
267-269[CrossRef][Medline]
[Order article via Infotrieve]
12.
Jones, S. A.,
O'Donnell, V. B.,
Wood, J. D.,
Broughton, J. P.,
Hughes, E. J.,
and Jones, O. T.
(1996)
Am. J. Physiol.
271,
H1626-H1634[Medline]
[Order article via Infotrieve]
13.
Bayraktutan, U.,
Blayney, L.,
and Shah, A. M.
(2000)
Arterioscler. Thromb. Vasc. Biol.
20,
1903-1911 14.
Li, J. M.,
and Shah, A. M.
(2001)
Cardiovasc. Res.
52,
477-486 15.
Matoba, T.,
Shimokawa, H.,
Nakashima, M.,
Hirakawa, Y.,
Mukai, Y.,
Hirano, K.,
Kanaide, H.,
and Takeshita, A.
(2000)
J. Clin. Invest.
106,
1521-1530[Medline]
[Order article via Infotrieve]
16.
Lee, Y. W.,
Kuhn, H.,
Hennig, B.,
Neish, A. S.,
and Toborek, M.
(2001)
J. Mol. Cell. Cardiol.
33,
83-94[CrossRef][Medline]
[Order article via Infotrieve]
17.
Matsubara, T.,
and Ziff, M.
(1986)
J. Immunol.
137,
3295-3298[Abstract]
18.
Holland, J. A.,
Pritchard, K. A.,
Pappolla, M. A.,
Wolin, M. S.,
Rogers, N. J.,
and Stemerman, M. B.
(1990)
J. Cell. Physiol.
143,
21-25[CrossRef][Medline]
[Order article via Infotrieve]
19.
Schimizu, S.-I.,
Ishii, M.,
Yamamoto, T.,
Kawanishi, T.,
Momose, K.,
and Kuroiwa, Y.
(1994)
Res. Commun. Chem. Pathol. Pharmacol.
84,
301-314[Medline]
[Order article via Infotrieve]
20.
Gardner, C. R.,
Laskin, J. D.,
and Laskin, D. L.
(1993)
J. Leukocyte Biol.
53,
190-196[Abstract]
21.
Abid, M. R.,
Tsai, J. C.,
Spokes, K. C.,
Deshpande, S. S.,
Irani, K.,
and Aird, W. C.
(2001)
FASEB J.
15,
2548-2550 22.
Toborek, M.,
Blanc, E. M.,
Kaiser, S.,
Mattson, M. P.,
and Hennig, B.
(1997)
J. Lipid Res.
38,
2155-2167[Abstract]
23.
Murphy, H. S.,
Shayman, J. A.,
Till, G. O.,
Mahrougui, M.,
Owens, C. B.,
Ryan, U. S.,
and Ward, P. A.
(1992)
Am. J. Physiol.
263,
L51-L59[Medline]
[Order article via Infotrieve]
24.
Deshpande, S. S.,
Angkeow, P.,
Huang, J.,
Ozaki, M.,
and Irani, K.
(2000)
FASEB J.
14,
1705-1714 25.
Rahman, A.,
Anwar, K. N.,
and Malik, A. B.
(2000)
Am. J. Physiol.
279,
C906-C914
26.
Zhang, H.,
Schmeisser, A.,
Garlichs, C. D.,
Plotze, K.,
Damme, U.,
Mugge, A.,
and Daniel, W. G.
(1999)
Cardiovasc. Res.
44,
215-222 27.
Lang, D.,
Mosfer, S. I.,
Shakesby, A.,
Donaldson, F.,
and Lewis, M. J.
(2000)
Circ. Res.
86,
463-469 28.
Holland, J. A.,
Meyer, J. W.,
Chang, M. M.,
O'Donnell, R. W.,
Johnson, D. K.,
and Ziegler, L. M.
(1998)
Endothelium.
6,
113-121[Medline]
[Order article via Infotrieve]
29.
Hu, Q.,
Zheng, G.,
Zweier, J. L.,
Deshpande, S.,
Irani, K.,
and Ziegelstein, R. C.
(2000)
J. Biol. Chem.
275,
15749-15757 30.
Jacob, R.,
Merritt, J. E.,
Hallam, T. J.,
and Rink, T. J.
(1988)
Nature
335,
40-45[CrossRef][Medline]
[Order article via Infotrieve]
31.
Carter, T. D.,
Bogle, R. G.,
and Bjaaland, T.
(1991)
Biochem. J.
278,
697-704[Medline]
[Order article via Infotrieve]
32.
Rink, T. J.,
and Hallam, T. J.
(1989)
Cell Calcium
10,
385-395[CrossRef][Medline]
[Order article via Infotrieve]
33.
Clapham, D. E.
(1995)
Cell
80,
259-268[CrossRef][Medline]
[Order article via Infotrieve]
34.
Sneyd, J.,
Keizer, J.,
and Sanderson, M. J.
(1995)
FASEB J.
9,
1463-1472[Abstract]
35.
Hajnoczky, G.,
and Thomas, A. P.
(1997)
EMBO J.
16,
3533-3543[CrossRef][Medline]
[Order article via Infotrieve]
36.
Sulciner, D. J.,
Irani, K., Yu, Z. X.,
Ferrans, V. J.,
Goldschmidt-Clermont, P.,
and Finkel, T.
(1996)
Mol. Cell. Biol.
16,
7115-7121[Abstract]
37.
Ziegelstein, R. C.,
Cheng, L.,
Blank, P. S.,
Spurgeon, H. A.,
Lakatta, E. G.,
Hansford, R. G.,
and Capogrossi, M. C.
(1993)
Am. J. Physiol.
265,
H1424-H1433[Medline]
[Order article via Infotrieve]
38.
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450 39.
Hu, Q.,
Deshpande, S.,
Irani, K.,
and Ziegelstein, R. C.
(1999)
J. Biol. Chem.
274,
33995-33998 40.
Didsbury, J. R.,
Uhing, R. J.,
and Snyderman, R.
(1990)
Biochem. Biophys. Res. Commun.
171,
804-812[CrossRef][Medline]
[Order article via Infotrieve]
41.
Kinsella, B. T.,
Erdman, R. A.,
and Maltese, W. A.
(1991)
J. Biol. Chem.
266,
9786-9794 42.
Kovacic, H. N.,
Irani, K.,
and Goldschmidt-Clermont, P. J.
(2001)
J. Biol. Chem.
276,
45856-45861 43.
Hu, Q.,
Corda, S.,
Zweier, J. L.,
Capogrossi, M. C.,
and Ziegelstein, R. C.
(1998)
Circulation
97,
268-275 44.
Pollock, W. K.,
Wreggett, K. A.,
and Irvine, R. F.
(1988)
Biochem. J.
256,
371-376[Medline]
[Order article via Infotrieve]
45.
Lechleiter, J.,
Girard, S.,
Peralta, E.,
and Clapham, D.
(1991)
Science
252,
123-126 46.
Renard-Rooney, D. C.,
Joseph, S. K.,
Seitz, M. B.,
and Thomas, A. P.
(1995)
Biochem. J.
310,
185-192[Medline]
[Order article via Infotrieve]
47.
Renard, D. C.,
Seitz, M. B.,
and Thomas, A. P.
(1992)
Biochem. J.
284,
507-512[Medline]
[Order article via Infotrieve]
48.
Nomura, T.,
Higashi, K.,
Hoshino, M.,
Saso, K.,
Itou, M.,
and Hoek, J. B.
(1996)
Alcohol. Clin. Exp. Res.
20,
325A-329A[Medline]
[Order article via Infotrieve]
49.
Parinandi, N. L.,
Scribner, W. M.,
Vepa, S.,
Shi, S.,
and Natarajan, V.
(1999)
Antioxid. Redox Signal.
1,
193-210[Medline]
[Order article via Infotrieve]
50.
Hu, Q.,
Natarajan, V.,
and Ziegelstein, R. C.
(2002)
Biochem. Biophys. Res. Commun.
292,
325-332[CrossRef][Medline]
[Order article via Infotrieve]
51.
Venema, V. J., Ju, H.,
Sun, J.,
Eaton, D. C.,
Marrero, M. B.,
and Venema, R. C.
(1998)
Biochem. Biophys. Res. Commun.
246,
70-75[CrossRef][Medline]
[Order article via Infotrieve]
52.
Goldkorn, T.,
Balaban, N.,
Matsukuma, K.,
Chea, V.,
Gould, R.,
Last, J.,
Chan, C.,
and Chavez, C.
(1998)
Am. J. Respir. Cell Mol. Biol.
19,
786-798 53.
Paltauf-Doburzynska, J.,
Frieden, M.,
Spitaler, M.,
and Graier, W. F.
(2000)
J. Physiol.
524,
701-713 54.
Anzai, K.,
Ogawa, K.,
Ozawa, T.,
and Yamamoto, H.
(2000)
Antioxid. Redox Signal.
2,
35-40[Medline]
[Order article via Infotrieve]
55.
Pessah, I. N.,
and Feng, W.
(2000)
Antioxid. Redox Signal.
2,
17-25[Medline]
[Order article via Infotrieve]
56.
Feng, W.,
Liu, G.,
Allen, P. D.,
and Pessah, I. N.
(2000)
J. Biol. Chem.
275,
35902-35907 57.
Lee, Z. W.,
Kweon, S. M.,
Kim, S. J.,
Kim, J. H.,
Cheong, C.,
Park, Y. M.,
and Ha, K. S.
(2000)
Cell Signal.
12,
91-98[CrossRef][Medline]
[Order article via Infotrieve]
58.
Vercellotti, G. M.,
Severson, S. P.,
Duane, P.,
and Moldow, C. F.
(1991)
J. Lab. Clin. Med.
117,
15-24[Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. H. Edwards, Y. Li, and T. M. Griffith Hydrogen Peroxide Potentiates the EDHF Phenomenon by Promoting Endothelial Ca2+ Mobilization Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1774 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhu, Y. Luo, T. Chen, F. Chen, T. Wang, and Q. Hu Ca2+ oscillation frequency regulates agonist-stimulated gene expression in vascular endothelial cells J. Cell Sci., August 1, 2008; 121(15): 2511 - 2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Davidson and M. R. Duchen Endothelial Mitochondria: Contributing to Vascular Function and Disease Circ. Res., April 27, 2007; 100(8): 1128 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cardenas, S. T. McKenna, J. G. Kunkel, and P. K. Hepler NAD(P)H Oscillates in Pollen Tubes and Is Correlated with Tip Growth Plant Physiology, December 1, 2006; 142(4): 1460 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Camello-Almaraz, P. J. Gomez-Pinilla, M. J. Pozo, and P. J. Camello Mitochondrial reactive oxygen species and Ca2+ signaling Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1082 - C1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Hong, S. J. Moon, H. M. Byun, M. S. Kim, H. Jo, Y. S. Bae, S.-I. Lee, M. D. Bootman, H. L. Roderick, D. M. Shin, et al. Critical Role of Phospholipase C{gamma}1 in the Generation of H2O2-evoked [Ca2+]i Oscillations in Cultured Rat Cortical Astrocytes J. Biol. Chem., May 12, 2006; 281(19): 13057 - 13067. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brueckl, S. Kaestle, A. Kerem, H. Habazettl, F. Krombach, H. Kuppe, and W. M. Kuebler Hyperoxia-Induced Reactive Oxygen Species Formation in Pulmonary Capillary Endothelial Cells In Situ Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 453 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Aley, K. E. Porter, J. P. Boyle, P. J. Kemp, and C. Peers Hypoxic Modulation of Ca2+ Signaling in Human Venous Endothelial Cells: MULTIPLE ROLES FOR REACTIVE OXYGEN SPECIES J. Biol. Chem., April 8, 2005; 280(14): 13349 - 13354. [Abstract] [Full Text] [PDF] |
||||
![]() |